The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-((3-(benzo[d]thiazol-2-yl)phenylamino)methylene)-2,2-dimethyl-1,3-dioxane-4,6-dione ID: ALA1078340
PubChem CID: 46882631
Max Phase: Preclinical
Molecular Formula: C20H16N2O4S
Molecular Weight: 380.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)OC(=O)C(=CNc2cccc(-c3nc4ccccc4s3)c2)C(=O)O1
Standard InChI: InChI=1S/C20H16N2O4S/c1-20(2)25-18(23)14(19(24)26-20)11-21-13-7-5-6-12(10-13)17-22-15-8-3-4-9-16(15)27-17/h3-11,21H,1-2H3
Standard InChI Key: UZIRVOZNNDDYEZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
6.8429 -25.8266 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.0227 -25.7217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6727 -26.4708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2752 -27.0356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9980 -26.6376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7039 -27.0643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6869 -27.8889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9641 -28.2870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2582 -27.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2612 -20.7161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8486 -20.0019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0235 -20.0019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6109 -20.7161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0235 -21.4304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8486 -21.4304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7858 -20.7161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2612 -22.1446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6109 -22.1446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0235 -22.8588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6109 -23.5731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0235 -24.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6109 -25.0062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7858 -25.0062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3732 -24.2873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7858 -23.5731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4314 -19.2852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5591 -19.5832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
10 15 1 0
13 16 2 0
15 17 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
20 25 2 0
19 20 1 0
18 19 1 0
14 18 2 0
1 5 1 0
11 26 1 0
6 7 1 0
11 27 1 0
22 2 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 380.43Molecular Weight (Monoisotopic): 380.0831AlogP: 4.10#Rotatable Bonds: 3Polar Surface Area: 77.52Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.35CX Basic pKa: 2.02CX LogP: 4.30CX LogD: 4.30Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.42Np Likeness Score: -1.55
References 1. Darque A, Dumètre A, Hutter S, Casano G, Robin M, Pannecouque C, Azas N.. (2009) Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates., 19 (20): [PMID:19748781 ] [10.1016/j.bmcl.2009.08.013 ]